Application Effect of Ciprofol in Anesthesia for Thoracoscopic Surgery: A Prospective, Randomized, Double-Blind, Controlled Trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2500109542

Enrollment

Unknown

Registered

2025-09-22

Start date

2025-09-30

Completion date

Unknown

Last updated

2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The application effects of Ciprofol

Interventions

C group:Using ciprofol for total intravenous anesthesia induction and maintenance

P group:Using propofol for total intravenous anesthesia induction and maintenance

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Age 18 to 65 years old 2.BMI:18.5<=BMI<=28kg/m^2 3.ASA:?~?.

Exclusion criteria

Exclusion criteria: 1.The patient refuses to participate in the study 2.Allergy to Ciprofol and related medications 3.Patients on long-term sedatives, antidepressants, or hormone therapy 4.Cognitive dysfunction or inability to communicate 5.The surgical method was changed to thoracotomy

Design outcomes

Primary

Measure	Time frame
satisfaction;	—

Secondary

Measure	Time frame
Incidence rate of injection pain;Cognitive function;Duration of surgery and anesthesia;Time of endotracheal tube extubation;Duration of one-lung ventilation;	—

Countries

China

Contacts

Public ContactHongyu Xu

Zibo Central Hospital

xuhy009@163.com+86 186 7818 6930

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026